Calcium Acetate Tablets
Calcium Acetate Tablets are a phosphate-binding agent used to control high blood phosphate levels in patients with chronic kidney disease (CKD), especially those undergoing dialysis. The product works by binding dietary phosphate in the gastrointestinal tract to form insoluble calcium phosphate, which is then excreted, helping maintain normal phosphate and calcium balance in the body.
It plays a crucial role in preventing renal osteodystrophy and other complications caused by excess phosphate in CKD patients.
Calcium Acetate is a calcium salt of acetic acid that acts as a dietary phosphate binder.
Each tablet contains Calcium Acetate (667 mg or 800 mg), equivalent to approximately 169–200 mg elemental calcium.
The formulation reduces phosphate absorption from food, thus helping maintain normal serum phosphate and parathyroid hormone (PTH) levels in CKD patients.
It is available as film-coated tablets or chewable tablets for easy administration.
Treatment and management of hyperphosphataemia in chronic kidney disease (CKD), particularly in dialysis patients.
Helps prevent renal bone disease and vascular calcification associated with high phosphate levels.
Maintains phosphate balance and supports calcium homeostasis.
Used as part of dietary therapy in CKD patients on restricted phosphate diets.
Effective phosphate control with a calcium-based binder.
Helps maintain strong bone health in CKD patients.
Rapid onset of action and excellent gastrointestinal tolerability.
Reduces need for synthetic non-calcium binders in mild-to-moderate CKD cases.
Safe and effective for long-term use under medical supervision.
Suitable as an adjunct to low-phosphate diet therapy.